Adherence rates and reasons for extending SCIT administration
intervals
104 (31.8%) patients (Group 3) were considered as non-adherent whereas
72 (22%) patients (Group 2) who extended injection intervals for less
than 2 months and 151 (46%) patients (Group 1) who received injections
on routine injection visits were adherent.
The reasons for extending the SCIT administration intervals during the
pandemic in Group 2 (n=72) in decreasing significance order were as
follows; staying at home due to precautionary reasons for 33 patients
(45.8%), unwilling to go to the hospital for 18 patients (25%),
transportation problems for 6 patients (8.3%), delay in the import of
the vaccine for 4 patients (5.6%), having acute COVID-19 for 4 patients
(5.6%), the thought that allergy clinics were closed during the
pandemic for 4 patients (5.6%) and personal reasons unrelated to the
pandemic for 3 patients (4.2%).
In Group 3, the reasons of non-adherence were; staying at home due to
precautionary reasons for 48 patients (46.2%), unwilling to go to the
hospital for 12 patients (11.5%), transportation problems for 17
patients (16.4%), delay in the import of the vaccine for 16 patients
(15.4%), having acute COVID-19 for 5 patients (4.8%), having a health
problem other than COVID-19 for 2 patients (1.9%), the thought that
allergy clinics were closed during the pandemic for 2 patients (1.9%)
and personal reasons unrelated to the pandemic for 2 patients (1.9%),
respectively.
Univariate analysis revealed that AIT with HDM and public transport
usage were higher in the non-adherent group than the adherent group
(p=0.003, p=0.010, respectively) whereas the patients receiving pollen
SCIT with or without another concomitant allergen (n=96) were more
adherent (p=0.003) (Table 1). In the logistic regression analysis, AIT
with HDM and public transport usage were significantly higher among
non-adherent patients (patients in Group 3) than adherent patients
(patients in Group 1 and Group 2) (p=0.009, p=0.026, respectively)
(Table 2).